Literature DB >> 9814812

Mitral valve operation via Port Access versus median sternotomy.

D D Glower1, K P Landolfo, F Clements, N P Debruijn, M Stafford-Smith, P K Smith, F Duhaylongsod.   

Abstract

OBJECTIVE: The advantages and disadvantages of minimally invasive Port Access mitral valve operation have not been defined relative to standard median sternotomy. A study was therefore designed to delineate differences in outcome from mitral operation via Port Access versus sternotomy in comparable patients.
METHODS: The records of 41 consecutive patients undergoing isolated mitral valve replacement (n = 14) or repair (n = 27) were examined. All operations were performed using cardioplegic arrest through either median sternotomy (n = 20) or a small right anterolateral thoracotomy using an endoaortic clamp and catheter system (Heartport, Redwood City, CA) to arrest and decompress the heart (Port Access, n = 21).
RESULTS: Both groups were well matched for age, mitral pathology, ejection fraction, and comorbidity. except that Port Access patients were less likely to be female. Three patients had undergone previous cardiac operations. Surgical procedure time was longer for Port Access patients (384+/-80 vs. 263+/-41 min, P < 0.05). Port Access provided significantly smaller incision length (8+/-2 vs. 26+/-2 cm, P < 0.01) and similar or shorter hospital stay (6+/-4 vs. 7+/-3 days). Port Access provided excellent visualization of the mitral valve and subvalvular apparatus, generally better than sternotomy, to allow complex mitral valve repairs. The greatest advantage of Port Access mitral operation was that Port Access patients returned to normal activity more rapidly (4+/-2 vs. 9+/-1 weeks, P = 0.01) than did patients undergoing standard median sternotomy.
CONCLUSIONS: By avoiding a sternotomy, Port Access mitral valve operation provided a smaller incision and a dramatically more rapid return to normal activity than did median sternotomy. Port Access cardioplegic arrest with the Heartport system allowed visualization of the mitral valve superior to median sternotomy and has become the standard approach at this institution.

Entities:  

Mesh:

Year:  1998        PMID: 9814812     DOI: 10.1016/s1010-7940(98)00123-7

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  20 in total

Review 1.  Multivessel coronary bypass grafting with minimal access using cardiopulmonary bypass.

Authors:  M Groh; E A Grossi
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

Review 2.  Is minimally invasive heart valve surgery a paradigm for the future?

Authors:  A M Gillinov; M K Banbury; D M Cosgrove
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

3.  How to set-up a program of minimally-invasive surgery for congenital heart defects.

Authors:  Juan-Miguel Gil-Jaurena; Ramón Pérez-Caballero; Ana Pita-Fernández; María-Teresa González-López; Jairo Sánchez; Juan-Carlos De Agustín
Journal:  Transl Pediatr       Date:  2016-07

Review 4.  Minimally invasive mitral valve repair.

Authors:  Mateo Marin Cuartas; Piroze Minoo Davierwala
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-07-27

Review 5.  Minimally invasive surgery of mitral valve (MIS-MV).

Authors:  Mikihiko Kudo; Ryohei Yozu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-11

6.  The right vertical infra-axillary incision for mitral valve replacement.

Authors:  Qing-guo Li; Qiang Wang; Dong-jin Wang
Journal:  J Cardiothorac Surg       Date:  2010-11-07       Impact factor: 1.637

Review 7.  Minimally invasive valve surgery.

Authors:  Nicolas H Pope; Gorav Ailawadi
Journal:  J Cardiovasc Transl Res       Date:  2014-05-06       Impact factor: 4.132

8.  A novel shape memory alloy annuloplasty ring for minimally invasive surgery: design, fabrication, and evaluation.

Authors:  Molly F Purser; Andrew L Richards; Richard C Cook; Jason A Osborne; Denis R Cormier; Gregory D Buckner
Journal:  Ann Biomed Eng       Date:  2010-07-23       Impact factor: 3.934

9.  Is minimally invasive thoracoscopic surgery the new benchmark for treating mitral valve disease?

Authors:  Andrew B Goldstone; Y Joseph Woo
Journal:  Ann Cardiothorac Surg       Date:  2016-11

10.  Retrograde femoral arterial perfusion and stroke risk during minimally invasive mitral valve surgery: is there cause for concern?

Authors:  Paul Modi; W Randolph Chitwood
Journal:  Ann Cardiothorac Surg       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.